AIM ImmunoTech's total assets for Q4 2024 were $8.61M, a decrease of -36.65% from the previous quarter. AIM total liabilities were $9.93M for the fiscal quarter, a -6.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.